Carlson College of Veterinary Medicine

Y. Yamazaki, Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B., Petrofsky, M., Bildfell, R., and Bermudez, L. E., “The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells.”, Cell Microbiol, vol. 8, no. 5, pp. 806-14, 2006.

D. Wagner, Maser, J., Moric, I., Vogt, S., Kern, W. V., and Bermudez, L. E., “Elemental analysis of the Mycobacterium avium phagosome in Balb/c mouse macrophages.”, Biochemical and biophysical research communications, vol. 344, no. 4, pp. 1346-51, 2006.

T. Dam, Danelishvili, L., Wu, M., and Bermudez, L. E., “The fadD2 gene is required for efficient Mycobacterium avium invasion of mucosal epithelial cells.”, The Journal of infectious diseases, vol. 193, no. 8, pp. 1135-42, 2006.

T. Dam, Danelishvili, L., Wu, M., and Bermudez, L. E., “The fadD2 gene is required for efficient Mycobacterium avium invasion of mucosal epithelial cells.”, J Infect Dis, vol. 193, no. 8, pp. 1135-42, 2006.

M. L. Kent, Watral, V., Wu, M., and Bermudez, L. E., “In vivo and in vitro growth of Mycobacterium marinum at homoeothermic temperatures.”, FEMS microbiology letters, vol. 257, no. 1, pp. 69-75, 2006.

L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microbial drug resistance (Larchmont, N.Y.), vol. 12, no. 1, pp. 1-6, 2006.

L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microb Drug Resist, vol. 12, no. 1, pp. 1-6, 2006.

L. E. Bermudez, Danelishvili, L., and Early, J., “Mycobacteria and Macrophage Apoptosis: Complex Struggle for Survival.”, Microbe Wash DC, vol. 1, no. 8, pp. 372-375, 2006.

Y. Yamazaki, Danelishvili, L., Wu, M., Macnab, M., and Bermudez, L. E., “Mycobacterium avium genes associated with the ability to form a biofilm.”, Appl Environ Microbiol, vol. 72, no. 1, pp. 819-25, 2006.

Y. Yamazaki, Danelishvili, L., Wu, M., Macnab, M., and Bermudez, L. E., “Mycobacterium avium genes associated with the ability to form a biofilm.”, Applied and environmental microbiology, vol. 72, no. 1, pp. 819-25, 2006.

R. Tenant and Bermudez, L. E., “Mycobacterium avium genes upregulated upon infection of Acanthamoeba castellanii demonstrate a common response to the intracellular environment.”, Current microbiology, vol. 52, no. 2, pp. 128-33, 2006.

M. Petrofsky and Bermudez, L. E., “CD4+ T cells but Not CD8+ or gammadelta+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route.”, Infection and immunity, vol. 73, no. 5, pp. 2621-7, 2005.

R. Roy MacGregor, Hafner, R., Wu, J. W., Murphy, R. L., Perlman, D. C., Bermudez, L. E., Inderlied, C. B., Picker, L. J., Wallis, R. S., Andersen, J. W., Mahon, L. F., Koletar, S. L., and Peterson, D. M., “Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.”, AIDS research and human retroviruses, vol. 21, no. 8, pp. 689-95, 2005.

D. Wagner, Maser, J., Lai, B., Cai, Z., Barry, C. E., Bentrup, K. Höner Zu, Russell, D. G., and Bermudez, L. E., “Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system.”, Journal of immunology (Baltimore, Md. : 1950), vol. 174, no. 3, pp. 1491-500, 2005.

D. Wagner, Sangari, F. J., Parker, A., and Bermudez, L. E., “fecB, a gene potentially involved in iron transport in Mycobacterium avium, is not induced within macrophages.”, FEMS microbiology letters, vol. 247, no. 2, pp. 185-91, 2005.

L. Danelishvili, Wu, M., Young, L. S., and Bermudez, L. E., “Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.”, Antimicrobial agents and chemotherapy, vol. 49, no. 9, pp. 3707-14, 2005.

L. Danelishvili, Wu, M., Young, L. S., and Bermudez, L. E., “Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.”, Antimicrob Agents Chemother, vol. 49, no. 9, pp. 3707-14, 2005.

E. Miltner, Daroogheh, K., Mehta, P. K., Cirillo, S. L. G., Cirillo, J. D., and Bermudez, L. E., “Identification of Mycobacterium avium genes that affect invasion of the intestinal epithelium.”, Infection and immunity, vol. 73, no. 7, pp. 4214-21, 2005.

Y. Li, Miltner, E., Wu, M., Petrofsky, M., and Bermudez, L. E., “A Mycobacterium avium PPE gene is associated with the ability of the bacterium to grow in macrophages and virulence in mice.”, Cellular microbiology, vol. 7, no. 4, pp. 539-48, 2005.

L. E. Bermudez and Yamazaki, Y., “Effects of macrolides and ketolides on mycobacterial infections.”, Current pharmaceutical design, vol. 10, no. 26, pp. 3221-8, 2004.

L. Danelishvili, Poort, M. J., and Bermudez, L. E., “Identification of Mycobacterium avium genes up-regulated in cultured macrophages and in mice.”, FEMS Microbiol Lett, vol. 239, no. 1, pp. 41-9, 2004.

L. Danelishvili, Poort, M. J., and Bermudez, L. E., “Identification of Mycobacterium avium genes up-regulated in cultured macrophages and in mice.”, FEMS microbiology letters, vol. 239, no. 1, pp. 41-9, 2004.

L. E. Bermudez, Petrofsky, M., and Sangari, F., “Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype.”, Cell biology international, vol. 28, no. 5, pp. 411-9, 2004.

O. Chacon, Bermudez, L. E., and Barletta, R. G., “Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis.”, Annual review of microbiology, vol. 58, pp. 329-63, 2004.

L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., “SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.”, Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.